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Despite widespread use of communicable disease 
surveillance data to inform public health intervention and 
control measures, the reporting completeness of the notiﬁ  -
able disease surveillance system remains incompletely as-
sessed. Therefore, we conducted a comprehensive study 
of reporting completeness with an analysis of 53 diseases 
reported by 8 health care systems across North Carolina, 
USA, during 1995–1997 and 2000–2006. All patients who 
were assigned an International Classiﬁ  cation of Diseases, 
9th Revision, Clinical Modiﬁ   cation, diagnosis code for a 
state-required reportable communicable disease were 
matched to surveillance records. We used logistic regres-
sion techniques to estimate reporting completeness by dis-
ease, year, and health care system. The completeness of 
reporting varied among the health care systems from 2% 
to 30% and improved over time. Disease-speciﬁ  c reporting 
completeness proportions ranged from 0% to 82%, but were 
generally low even for diseases with great public health im-
portance and opportunity for interventions.
S
urveillance has been the cornerstone of public health 
since the US Congress authorized the Public Health Ser-
vice to collect morbidity data for cholera, smallpox, plague, 
and yellow fever in 1878. Currently, all states conduct no-
tiﬁ  able disease surveillance following guidelines from the 
Centers for Disease Control and Prevention (CDC) and the 
Council for State and Territorial Epidemiologists. The cur-
rent list of nationally notiﬁ  able communicable diseases has 
expanded to >60 diseases and includes vaccine-preventable 
diseases (e.g., pertussis, measles), emerging infectious dis-
eases (e.g., severe acute respiratory syndrome, West Nile 
virus encephalitis), foodborne diseases (e.g., Shiga toxin–
producing  Escherichia coli and Salmonella spp. infec-
tions), sexually transmitted diseases (e.g., syphilis, HIV), 
and aerosol and droplet transmitted diseases (e.g., tubercu-
losis, meningococcal meningitis). Active surveillance pro-
grams conducted by CDC in conjunction with certain states 
include Active Bacterial Core surveillance, FoodNet, and 
inﬂ  uenza-related hospitalization surveillance. Surveillance 
of epidemiologically important diseases provides critical 
information to clinicians and public health ofﬁ  cials for use 
in measuring disease incidence in communities, recogniz-
ing disease outbreaks, assessing prevention and control 
measure effectiveness, allocating public health resources, 
and further clarifying the epidemiology of new and emerg-
ing pathogens (1).
Like all US states, North Carolina has state laws and 
regulations mandating communicable disease reporting 
(2–4). The state relies on physicians and laboratories to 
comply with the directive to report diseases and laboratory 
results indicative of diseases considered a threat to pub-
lic health. During the periods of this study (1995–1997, 
2000–2006), mandatory reporting was required for >60 
diseases. Conditions and disease reports consisted of paper 
communicable-disease report forms that contained demo-
graphic, clinical, and risk factor data for the case-patient. 
These reports were required to be submitted to the health 
department within a speciﬁ  ed period (i.e., immediately, 
within 24 hours, or within 7 days), depending on the dis-
ease. An important change to the communicable disease 
surveillance system of the North Carolina Department of 
Health and Human Services (NC DHHS) occurred when 
the state administrative code was amended in September 
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1998 to require that persons in charge of diagnostic labo-
ratories report positive laboratory results for most diseases 
already reportable by physicians (2). This dual reporting 
mechanism was intended to improve completeness, timeli-
ness, and accuracy of surveillance. More recently, in 2002, 
surveillance efforts have also expanded with the introduc-
tion of 7 regional public health teams and 11 hospital-based 
public health epidemiologists.
Despite the widespread use of these surveillance data, 
systematic data collection based on mandatory physician 
and laboratory reporting has never been extensively evalu-
ated. To date, only 2 evaluations have examined reporting 
proportions for >5 diseases (5,6). Previous studies exam-
ining the completeness of disease reporting have differed 
considerably in terms of the following factors: size of geo-
graphic region (e.g., from clinics at a single university to 
multiple states), range of study period (e.g., several months 
to several years), heterogeneity of reporting systems (e.g., 
health care provider–based passive reporting vs. health 
care provider– and laboratory-based passive reporting), 
and various patient ascertainment methods (e.g., labora-
tory records, billing records, active surveillance, death cer-
tiﬁ  cates). This variability renders study results difﬁ  cult to 
compare or aggregate. Therefore, we undertook a compre-
hensive study of reporting completeness with an analysis 
of 53 reportable diseases and conditions in selected health 
care systems across North Carolina over a 10-year period 
to estimate disease-speciﬁ  c reporting proportions, describe 
changes to reporting over time, and examine the variability 
of reporting completeness between health care facilities.
Methods
A retrospective cohort study was conducted at 8 large 
nonfederal acute care health care systems that experience 
32% of all inpatient visits and 23% of all outpatient visits 
in North Carolina (7). These health care systems ranged 
in size from 581 to 1,324 site-licensed beds, spanned the 
Eastern Coastal, Central Piedmont, and Western Mountain 
regions of the state, and were selected from a network of 
11 health care systems staffed with hospital-based pub-
lic health epidemiologists. The study cohort was deﬁ  ned 
as all inpatients and outpatients at the 8 health care sys-
tems who were assigned a discharge diagnostic code from 
the International Classiﬁ  cation of Diseases, 9th Revision, 
Clinical Modiﬁ  cation (ICD-9-CM), that corresponded with 
a reportable communicable diseases during a 10-year time 
period (1995–1997, 2000–2006). The years 1998–1999 
were excluded from the study because this period marked 
the transition when the state law was changed to include a 
reporting requirement for laboratories.
Diseases were excluded if they were chronic infec-
tious diseases that resulted in a recurring assignment of 
ICD-9-CM code (e.g., HIV, hepatitis B carrier), if no spe-
ciﬁ  c ICD-9-CM code was available (e.g., for viral hemor-
rhagic fever), or if the NC DHHS did not record patient 
identiﬁ  ers in their surveillance database during the entire 
study period (e.g., for syphilis, gonorrhea, chlamydia). Ap-
proval for the study was granted by the institutional review 
boards of all health care systems as well as by the North 
Carolina Division of Public Health because identiﬁ  able pa-
tient data were required to match the hospital and health 
department databases.
The cohort of patients assigned ICD-9-CM diagnostic 
codes by the health care systems for a reportable commu-
nicable disease were matched to the NC DHHS reported 
case-patients by using a unique identiﬁ  er created by either 
Social Security number, or a combination of the ﬁ  rst 2 let-
ters of the last name, ﬁ  rst letter of the ﬁ  rst name, date of 
birth, and a 2-digit disease code. Repeat patient visits with-
in a 31-day window for the same disease were enumerated 
and only the ﬁ  rst visit was retained, with the exception of 
tuberculosis, which had a 365-day window, and hepatitis A 
and paralytic polio, which were restricted to only the ﬁ  rst 
visit. Patients who had dates of reporting to the NC DHHS 
before the date of diagnosis at the health care system were 
excluded because they represented cases that had already 
been reported.
Unadjusted disease-speciﬁ   c reporting completeness 
proportions were calculated by dividing the number of 
case-patients that were reported to NC DHHS by the to-
tal number of patients identiﬁ  ed in the health care systems 
who were assigned an ICD-9-CM diagnostic code for a 
reportable disease. In addition, completeness proportions 
were estimated by year (1995–1997, 2000–2006) for the 
3 health care systems that had complete data available for 
all 10 years, and generalized linear regression models were 
used to examine the time trends. For the years 2000–2006, 
reporting completeness proportions and 95% conﬁ  dence 
intervals (CIs) were estimated for each health care system 
by using a binomial logistic regression model that included 
as covariates whether or not speciﬁ  c health care system 
personnel were designated for disease reporting.
For disease-speciﬁ  c completeness proportions, empiri-
cal continuity corrections were used when no patients were 
reported for a disease (8). In addition, adjusted complete-
ness proportions and 95% uncertainty intervals (UIs) were 
calculated by using semi-Bayesian analysis (9) as recom-
mended to reduce the mean squared error when an ensemble 
of measures are estimated (10). This semi-Bayesian hierar-
chical regression analysis uses prior covariates that help ex-
plain the mean of the ensemble of estimates and a speciﬁ  ed 
prior variance (τ2) of the distribution. Traditional maximum-
likelihood estimates (i.e., unadjusted estimates as presented 
here) can be viewed as a special case of semi-Bayesian anal-
ysis in which the prior variance is inﬁ  nite. By specifying 
even a moderately informative prior variance such as a τ2 
24  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 1, January 2011 Communicable Disease Reporting, NC, USA
indicating that 95% of all completeness proportions lie be-
tween 7.3% and 85%, an appreciable reduction in the over-
all mean squared error can be expected with a shift in the 
point estimate and a narrowing of the 95% UI for each com-
pleteness proportion, with the relative degree of narrowing 
being greater for diseases with less information.
A sensitivity analysis was conducted on the speciﬁ  ed 
prior variance, τ2, by using high, medium, and low τ2 values 
that assumed 95% of the completeness proportions were 
within the following ranges: 2.2%–95%, 7.3%–85%, and 
12.9%–75%, respectively. Sensitivity analyses were also 
conducted on the inclusion or exclusion of prior covariates, 
which were the time frame for reporting the disease (i.e., 
24 hours vs. 7 days), whether or not the disease had a re-
portable laboratory result, whether or not the disease had 
reportable serologic test results, whether or not the disease 
is classiﬁ  ed as a CDC category A bioterrorism agent, and 
the mode of transmission of the disease (person-to-person, 
arthropod-borne, food/water-borne, droplet/aerosol).
Results
Unadjusted and adjusted disease-speciﬁ  c complete-
ness proportions for 2000–2006 with 95% CIs and UIs, 
respectively, are summarized in the Table. The adjusted 
disease-speciﬁ   c, completeness proportions ranged from 
0% to 82.0%, and almost all diseases (49/53) had com-
pleteness proportions <50%. Eleven diseases accounted 
for 90% of disease reporting: salmonellosis, tuberculosis, 
meningococcal disease, Rocky Mountain spotted fever, 
campylobacteriosis, shigellosis, acute hepatitis A, pneu-
mococcal meningitis, legionellosis, malaria, and Hae-
mophilus inﬂ  uenzae invasive disease. Some unexpected 
diseases had cases identiﬁ  ed with an ICD-9-CM code; for 
example, anthrax had 14 cases identiﬁ  ed, paralytic polio 
had 32 cases identiﬁ  ed, human rabies had 12 cases identi-
ﬁ  ed, and smallpox had 9 cases identiﬁ  ed. The most dra-
matic adjustments in the unadjusted to adjusted point es-
timates were noted for staphylococcal foodborne disease, 
and for foodborne diseases caused by Vibrio vulniﬁ  cus and 
other Vibrio spp., with an ≈80% change in point estimate 
for the latter. However, wide UIs reﬂ  ect the imprecision in 
these estimates.
Figure 1 displays the overall reporting proportions by 
year for the 2 periods, 1995–1997, when only physicians 
were required to report most diseases, and 2000–2006, 
when  laboratories and physicians were required to report. 
Reporting increased signiﬁ  cantly in the second period, but 
was still low overall; the linear trend line slope was ≈0 and 
the intercept was 10.2%. Figure 2 displays the reporting 
proportions by health care system for the years 2000–2006. 
The completeness proportions ranged from 1.8% to 29.7% 
with an overall median proportion of 8.0%. The covari-
ates that described whether or not each health care system 
designated persons to report had no effect on a health care 
system’s reporting proportion.
The sensitivity analysis of the τ2 values showed that 
the point estimates and UIs were relatively insensitive to 
dramatic changes in τ2; for example, for meningococcal 
meningitis with a low τ2, the reporting proportion was es-
timated as 21% (95% UI 16%–28%), with a medium τ2, 
22% (95% UI 16%–28%); and with a high τ2, 22% (95% 
UI 16%–29%), and the sensitivity analyses examining the 
use of prior covariates were shown only to have effects 
on the reporting proportion and 95% UI for diseases with 
sparse data; for example, cholera with all prior covariates 
22% (95% UI 3%–74%), no prior covariates 10% (95% UI 
1%–51%), time covariate alone 50% (95% UI 10%–89%).
Discussion
The public health surveillance system in North Car-
olina is similar to surveillance systems used nationwide, 
and, although federal funding in addition to state and lo-
cal budgets support the infrastructure and maintenance of 
these systems, they are rarely evaluated with respect to the 
completeness of the communicable disease data reported. 
North Carolina’s size (ranked 11th in the 2000 US Census) 
and population diversity enabled a thorough evaluation of 
the completeness of reporting many reportable communi-
cable diseases that have rarely been evaluated in previous 
studies.
Disease-speciﬁ   c reporting completeness proportions 
were estimated to be low and varied greatly according to 
disease. Notably, even for diseases that require immedi-
ate public health intervention, we found that a low pro-
portion of cases were reported to the health department 
(e.g., meningococcal meningitis 21.2%, pertussis 20.3%). 
Further research studies should be undertaken to focus on 
methods to improve completeness and timeliness of case 
reporting, especially for these diseases that are severe and 
require immediate public health intervention. 
Variations in disease reporting can occur for several 
reasons. First, clinicians may have the perception that some 
diseases are a greater public health threat based on com-
municability or severity of the illness and the likelihood of 
death (e.g., tuberculosis vs. salmonellosis). Second, some 
diseases have relatively straightforward and primarily lab-
oratory-based case deﬁ  nitions (e.g., stool culture positive 
for Salmonella spp. infections with a clinically compatible 
illness), whereas others are more complex, either requiring 
multiple laboratory results (e.g., 4-fold increase between 
acute-phase and convalescent-phase serologic results for 
Rocky Mountain spotted fever) or a combination of mul-
tiple clinical signs and symptoms without any speciﬁ  c lab-
oratory result (e.g., toxic shock syndrome which, requires 
the presence of at least 4 symptoms). One clear pattern that 
emerged in our ﬁ  ndings was that diseases with fewer clini-
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Table . Disease-specific reporting completeness proportions in North Carolina, USA, 2000–2006* 
Communicable disease 
No. reported 
to NC DHHS 
No. identified by 
ICD-9-CM codes  Unadjusted RCP, % (95% CI)  
Semi-Bayesian adjusted 
RCP, % (95% UI)  
Anthrax 0 14 0.01 (0.00–100.00)  0.00 (0.00–100.00) 
Arboviral encephalitis  0 18 0.00 (0.00–100.00)  8.67 (0.80–52.77) 
Botulism  0 4 0.02 (0.00–100.00)  0.08 (0.00–100.00) 
Brucellosis 0 33 0.00 (0.00–100.00)  23.02 (1.36–86.62) 
Campylobacteriosis  39 97 40.21 (30.94–50.22)  39.96 (30.82–49.85) 
Cholera  0 6 0.01 (0.00–100.00)  18.58 (2.24–69.41) 
CJD/vCJD 0 32 0.00 (0.00–100.00)  0.87 (0.03–22.97) 
Cryptosporidiosis  10 84 11.90 (6.53–20.73)  12.59 (7.07–21.42) 
Cyclosporiasis  0 3 0.03 (0.00–100.00)  18.59 (2.25–69.42) 
Dengue  4 25 16.00 (6.14–35.69)  14.48 (5.92–31.31) 
Diphtheria  0 5 0.02 (0.00–100.00)  8.28 (0.82–49.70) 
Escherichia coli infection 1 3 33.33 (4.34–84.65)  24.67 (5.82–63.45) 
Foodborne staphylococcal infection  0 14 0.01 (0.00–100.00)  74.74 (16.74–97.76) 
Granulocytic ehrlichiosis  0 67 0.00 (0.00–100.00)  8.66 (0.80–52.74) 
Hantavirus infection  0 3 0.03 (0.00–100.00)  10.10 (0.62–67.06) 
Hemolytic uremic syndrome  5 429 1.17 (0.49–2.77)  2.20 (0.99–4.84) 
Hemophilus Influenzae 14 1,086  1.29 (0.76–2.16)  1.45 (0.87–2.42) 
Hepatitis A  27 866 3.12 (2.15–4.51)  3.34 (2.31–4.81) 
Legionellosis 24 98 24.49 (16.99–33.95)  24.04 (16.72–33.27) 
Leptospirosis 0 33 0.00 (0.00–100.00)  23.02 (1.36–86.62) 
Listeriosis 10 64 15.63 (8.62–26.67)  16.14 (9.12–26.95) 
Lyme disease  8 790 1.01 (0.51–2.01)  1.18 (0.60–2.30) 
Malaria 17 155 10.97 (6.93–16.94)  10.71 (6.80–16.47) 
Measles 0 14 0.01 (0.00–100.00)  15.98 (1.41–71.63) 
Meningococcal disease  38 179 21.23 (15.85–27.83)  21.19 (15.85–27.73) 
Monocytic ehrlichiosis  1 4 25.00 (3.35–76.22)  14.84 (3.12–48.52) 
Mumps 1 96 1.04 (0.15–7.02)  1.07 (0.20–5.49) 
Plague 0 28 0.00 (0.00–100.00)  0.00 (0.00–100.00) 
Pneumococcal meningitis  20 191 10.47 (6.86–15.67)  10.61 (6.99–15.80) 
Polio, paralytic  0 32 0.00 (0.00–100.00)  18.56 (2.24–69.38) 
Psittacosis  0 21 0.00 (0.00–100.00)  17.45 (1.57–73.69) 
Q fever  3 14 21.43 (7.07–49.43)  25.68 (9.14–54.28) 
Rabies, human  0 12 0.01 (0.00–100.00)  59.69 (8.00–96.19) 
Rocky Mountain spotted fever  40 986 4.06 (2.99–5.48)  4.19 (3.10–5.66) 
Rubella 0 39 0.00 (0.00–100.00)  15.97 (1.41–71.61) 
Rubella congenital syndrome  0 10 0.01 (0.00–100.00)  1.08 (0.07–15.32) 
Salmonellosis  263 594 44.28 (40.33–48.30)  44.82 (40.87–48.83) 
SARS (coronavirus infection)  0 1 0.08 (0.00–100.00)  5.71 (0.28–56.27) 
Shigellosis  38 213 17.84 (13.26–23.57)  18.17  (13.56–23.93) 
Smallpox 0 9 0.01 (0.00–100.00)  0.00 (0.00–100.00) 
Streptococcal infection, group A   8 111 7.21 (3.65–13.75)  7.40 (3.80–13.92) 
Tetanus  1 20 5.00 (0.70–28.22)  5.25 (1.09–21.78) 
Toxic shock syndrome  4 142 2.82 (1.06–7.26)  3.22 (1.28–7.83) 
Trichinosis 0 23 0.00 (0.00–100.00)  20.21 (1.82–77.58) 
Tuberculosis 100 1,439  6.95 (5.74–8.38)  7.10 (5.87–8.55) 
Tularemia  0 6 0.01 (0.00–100.00)  0.04 (0.00–100.00) 
Typhoid, acute  3 12 25.00 (8.28–55.18)  21.57 (7.49–48.30) 
Typhus, epidemic (louse-borne)  0 2 0.04 (0.00–100.00)  2.93 (0.12–42.63) 
Vaccinia  0 13 0.01 (0.00–100.00)  8.27 (0.82–49.68) 
Vibrio spp. infection, other  0 1 0.08 (0.00–100.00)  81.58 (20.46–98.71) 
Vibrio vulnificus infection 0 2 0.04 (0.00–100.00)  81.57 (20.45–98.71) 
Whooping cough (pertussis)  11 54 20.37 (11.65–33.16)  20.31 (11.78–32.72) 
Yellow fever  0 3 0.03 (0.00–100.00)  8.69 (0.80–52.81) 
*NC DHHS, North Carolina Department of Health and Human Services; ICD-9-CM, International Classification of Diseases, 9th Revision, Clinical 
Modification; RCP, reporting completeness proportions; CI, confidence interval; UI, uncertainty interval; CJD, Creutzfeldt-Jakob disease; vCJD, variant 
CJD; SARS, severe acute respiratory syndrome.   Communicable Disease Reporting, NC, USA
cal criteria and laboratory-based case deﬁ  nitions tended 
to have higher reporting rates (e.g., salmonellosis 44.8% 
vs. toxic shock syndrome 3.2%). Laboratory-based case 
deﬁ  nitions ensure that a dual reporting system exists, and 
the process is more straightforward because less time is re-
quired for reviewing medical records for clinical signs and 
symptoms. This ﬁ  nding underscores the need for simplic-
ity of case deﬁ  nitions, an essential attribute in surveillance 
system development and maintenance. Future research on 
predictors for reporting completeness would be useful for 
designing interventions to improve reporting and for guid-
ing the future direction of surveillance.
Notably, we identiﬁ  ed some patients by ICD-9-CM di-
agnostic codes for some diseases known to be eliminated in 
the United States (e.g., smallpox and polio) and others that 
were highly unlikely to have occurred (e.g., anthrax and 
human rabies). Numerous previous studies that have evalu-
ated reporting completeness have also used ICD-9-CM 
codes (5,6,11) because they are standard codes that can be 
queried relatively easily and should capture clinical cases 
of disease regardless of laboratory conﬁ  rmation. The ac-
curacy of the ICD-9-CM codes was a potential limitation in 
our study. Therefore, we also conducted a separate valida-
tion study of the positive predictive values of ICD-9-CM 
codes for communicable disease surveillance by using as 
the standard a complete medical record review and concor-
dance with published CDC case classiﬁ  cation criteria (12). 
These results showed that for most diseases with higher in-
cidence and relatively straightforward diagnoses, the posi-
tive predictive values (PPVs) were high (>80%) with the 
exception of tuberculosis, which had a PPV of 29% (13). 
For diseases with low PPVs, the estimates we present here 
are likely to be underestimates of the true reporting com-
pleteness because the completeness proportion denomina-
tor, or the number of patients identiﬁ  ed by ICD-9-CM codes 
for reportable diseases, is likely to be an overestimate (i.e., 
contain false-positive cases). However, an additional limi-
tation of this study was that we were unable to assess the 
sensitivity of ICD-9-CM codes (i.e., false-negative cases) 
for communicable disease reporting. Quantiﬁ  cation of the 
sensitivity and PPVs of ICD-9-CM codes for communica-
ble disease surveillance is essential in the interpretation of 
all ICD-9-CM data because these codes are used frequently 
for research studies and have been proposed as adjuncts to 
electronic, automated surveillance systems.
Bayesian analyses have been shown in theory, simu-
lation, and prediction problems to offer better estimates 
for measures as varied as baseball batting averages (14) 
and toxoplasmosis prevalence (15). We believe that the 
semi-Bayesian adjusted estimates offer improved overall 
accuracy for our ensemble of reporting completeness es-
timates. For example, for completeness proportions where 
the maximum-likelihood estimation methods result in 0% 
proportions, it is unlikely that the true proportion is actually 
0%. The use of semi-Bayesian methods enables us to in-
corporate additional prior covariate data to produce results 
that are likely better and more plausible than maximum-
likelihood estimation results. However, for estimates that 
were based on less information, we still observed wide UIs 
around the adjusted estimates. Speciﬁ  cally, we did note a 
dramatic shift in the reporting completeness proportions af-
ter semi-Bayesian adjustments for several diseases, includ-
ing staphylococcal foodborne disease and V.  vulniﬁ  cus and 
other Vibrio spp. infections. This shift reﬂ  ects the impreci-
sion in each disease’s measured estimates of reporting com-
pleteness and the adjustment or shrinkage of their propor-
tions to the mean of the prior covariate probability groups 
(i.e., food/water-borne transmission, and reporting time of 
24 hours). These estimates are shrunk toward the mean of 
the food/water-borne transmission group of diseases which 
includes many of those with the highest reporting propor-
tion (e.g., campylobacteriosis, salmonellosis). This ﬁ  nding 
reinforces the importance of careful speciﬁ  cation of prior 
covariates as well as judicious examination and interpre-
tation of the unadjusted and semi-Bayesian adjusted esti-
mates along with their precision.
The reporting variation seen among health care sys-
tems (Figure 2) may be explained in part by health care 
systems’ internal policies that assign the responsibility for 
communicable disease reporting to the infection preven-
tion department. For example, the health care system with 
the highest reporting proportion (health care system A) 
has hospital-based public health epidemiologists or infec-
tion preventionists responsible for disease reporting, and 
the health care system with the lowest reporting proportion 
(health care system G) does not assign any additional report-
ing responsibility beyond the state-mandated reporting by 
physicians and laboratories. However, adjusting for these 
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Figure 1. Reporting completeness of communicable diseases 
in North Carolina, USA, by year, with 95% conﬁ  dence intervals, 
2000–2006.RESEARCH
health care system policies did not modify the reporting 
completeness proportions. Currently, the North Carolina 
general statute states that medical facilities may report (16) 
as opposed to physicians and persons in charge of laborato-
ries who shall report (17,18). Because infection prevention-
ists typically receive laboratory data daily, are well-trained 
on case deﬁ  nition application, and share disease prevention 
goals with the health department, they can serve as partners 
to the local health department in ensuring that diseases are 
reported and investigated appropriately. However, redun-
dancy in disease reporting responsibilities could also cause 
reporting fatigue and the mistaken assumption that some-
one else has reported the case-patient (19,20). In addition, 
external generalizations of these ﬁ  ndings to other health 
care systems should be approached with caution because 
the participating sites were part of an existing network that 
includes the largest health care systems in North Carolina 
and therefore may have been more likely to treat patients 
who had more severe illnesses or who did not receive a 
diagnosis at a local clinic or smaller hospital.
Conclusions
The general trend of the yearly reporting completeness 
proportions suggests that disease reporting has improved 
over time yet remains low. Several notable changes oc-
curred in North Carolina’s surveillance system during this 
period. First, in 1998, the inclusion of laboratory-mandated 
reporting served as a secondary reporting mechanism in ad-
dition to the already mandated physician-based reporting. 
Regional public health teams were established in 2002 to 
assist health departments with outbreak investigations. In 
2003, a network of public health epidemiologists (funded 
through the state’s Public Health Emergency Preparedness 
cooperative agreement with CDC) were placed in hospitals 
to facilitate disease reporting and case investigation, and, 
also in 2003, a statewide emergency department–based 
syndromic surveillance system (North Carolina Disease 
Event Tracking and Epidemiologic Collection Tool) was 
created for early case identiﬁ  cation. Despite the likely posi-
tive effects of these regulatory and programmatic changes 
on disease reporting, the proportion of diseases reported 
remains low, as is consistent with data from other passive 
reporting surveillance systems (21). 
More recently, automated alerting and data collection 
for case-patients with reportable diseases (e.g., a positive 
blood culture result with gram-negative diplococci triggers 
an alert with case-patient contact information to infection 
preventionists, local health department staff, or both) has 
been shown to increase reporting rates when applied to tradi-
tional passive surveillance systems (22,23). Although North 
Carolina, like many states, has developed and implemented 
an electronic disease surveillance system, the reporting of 
communicable diseases by local health departments still re-
mains largely passive in that reporting is accomplished by 
accessing a secure Internet site and entering patient infor-
mation. Physicians who practice outside local health depart-
ments currently use paper-based reporting.
When health information exchange becomes a reality, 
public health surveillance can beneﬁ  t signiﬁ  cantly by au-
tomating processes that currently rely on manual data en-
try. Disease reporting could be automated by standardized 
queries directly from the electronic health records for key 
laboratory results (e.g., positive acid-fast bacillus sputum 
smear) and for simpliﬁ  ed or proxy clinical case deﬁ  nitions 
by using ICD-9-CM diagnosis codes or free-text admis-
sion diagnoses. Upon recognition of these potential case-
patients, automating surveillance data collection directly 
from electronic health records to populate data ﬁ  elds for 
basic patient demographics and laboratory results could 
also reduce administrative time for physicians and health 
department ofﬁ  cials and expedite communicable disease 
investigations.
This type of automated technology for electronic 
health records is consistent with The American Recov-
ery and Reinvestment Act of 2009, which authorizes the 
Centers for Medicare and Medicaid Services to provide 
reimbursement incentives for health care entities who are 
“meaningful users” of certiﬁ   ed electronic health record 
technology. In fact, the recent draft recommendations for 
deﬁ  ning “meaningful use” from the Health Information 
Technology Policy Council to the National Coordinator 
propose that hospitals be capable of providing electronic 
submission of reportable laboratory results to public health 
agencies by 2011 (24). Such an undertaking will require 
implementation of national laboratory reporting standards 
for hospitals and can only be accomplished with resource 
allocation and partnerships between health departments 
and health care systems. Furthermore, additional surveil-
lance research should investigate the sensitivity, speciﬁ  c-
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Figure 2. Reporting completeness of communicable diseases in 
North Carolina, USA, by health care system, 2000–2006. Error 
bars indicate 95% conﬁ  dence intervals. Communicable Disease Reporting, NC, USA
ity, and feasibility of using different key laboratory results 
and proxy clinical case deﬁ  nitions (e.g., ICD-9-CM codes) 
for automating the identiﬁ  cation of potential case-patients. 
The “meaningful use” of the electronic health record for 
automated case-ﬁ  nding and data collection will transition 
our current public health surveillance system from passive 
to active and thereby overcome the major barriers to com-
plete, accurate and timely communicable disease reporting 
and surveillance.
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